The Prognostic Impact of Preoperative Serum Apolipoprotein A-I in Patients with Esophageal Basaloid Squamous Cell Carcinoma

References

• WainSL, KierR, VollmerRT, et al. Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases. Hum Pathol. 1986;17(11):1158–1166. doi:10.1016/S0046-8177(86)80422-13770734
   PubMed Web of Science ®Google Scholar
• LamKY, LawS, LukJM, et al. Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator. J Pathol. 2001;195(4):435–442. doi:10.1002/path.98411745675
   PubMed Web of Science ®Google Scholar
• ZhangBH, ChengGY, XueQ, et al. Clinical outcomes of basaloid squamous cell carcinoma of the esophagus: a retrospective analysis of 142 cases. Asian Pac J Cancer Prev. 2013;14(3):1889–1894. doi:10.7314/APJCP.2013.14.3.188923679289
   PubMedGoogle Scholar
• XiaoQ, ZhangB, DengX, et al. The preoperative neutrophil-to-lymphocyte ratio is a novel immune parameter for the prognosis of esophageal basaloid squamous cell carcinoma. PLoS One. 2016;11(12):e0168299. doi:10.1371/journal.pone.016829927959959
   PubMed Web of Science ®Google Scholar
• Sato-KuwabaraY, FregnaniJH, JampietroJ, et al. Comparative analysis of basaloid and conventional squamous cell carcinomas of the esophagus: prognostic relevance of clinicopathological features and protein expression. Tumour Biol. 2016;37(5):6691–6699. doi:10.1007/s13277-015-4551-326649862
   PubMedGoogle Scholar
• SaitoT, MitomiH, YaoT. Molecular pathology and potential therapeutic targets in esophageal basaloid squamous cell carcinoma. Int J Clin Exp Pathol. 2015;8:2267–2273.26045734
   PubMed Web of Science ®Google Scholar
• ChangSJ, HouMF, TsaiSM, et al. The association between lipid profiles and breast cancer among Taiwanese women. Clin Chem Lab Med. 2007;45(9):1219–1223. doi:10.1515/CCLM.2007.26317663634
   PubMed Web of Science ®Google Scholar
• ZhangX, ZhaoXW, LiuDB, et al. Lipid levels in serum and cancerous tissues of colorectal cancer patients. World J Gastroenterol. 2014;20(26):8646–8652. doi:10.3748/wjg.v20.i26.864625024621
   PubMed Web of Science ®Google Scholar
• ChettyPS, MayneL, Lund-KatzS, et al. Helical structure and stability in human apolipoprotein A-I by hydrogen exchange and mass spectrometry. Proc Natl Acad Sci USA. 2009;106(45):19005–19010. doi:10.1073/pnas.090970810619850866
   PubMed Web of Science ®Google Scholar
• Zamanian-DaryoushM, LindnerD, TallantTC, et al. The cardioprotective protein apolipoprotein A1 promotes potent antitumorigenic effects. J Biol Chem. 2013;288(29):21237–21252. doi:10.1074/jbc.M113.46896723720750
   PubMed Web of Science ®Google Scholar
• FuhrmanB, GantmanA, AviramM. Paraoxonase 1 (PON1) deficiency in mice is associated with reduced expression of macrophage SR-BI and consequently the loss of HDL cytoprotection against apoptosis. Atherosclerosis. 2010;211(1):61–68. doi:10.1016/j.atherosclerosis.2010.01.02520149374
   PubMed Web of Science ®Google Scholar
• BhattacharyyaT, NichollsSJ, TopolEJ, et al. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA. 2008;299(11):1265–1276. doi:10.1001/jama.299.11.126518349088
   PubMed Web of Science ®Google Scholar
• MaM, YuanSQ, ChenYM, et al. Preoperative apolipoprotein B/apolipoprotein A1 ratio: a novel prognostic factor for gastric cancer. Onco Targets Ther. 2018;11:2169–2176. doi:10.2147/OTT.S15669029713185
   PubMed Web of Science ®Google Scholar
• MaoM, WangX, ShengH, et al. A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients. BMC Cancer. 2018;18(1):1178. doi:10.1186/s12885-018-5028-830486825
   PubMed Web of Science ®Google Scholar
• JiangR, YangZH, LuoDH, et al. Elevated apolipoprotein A-I levels are associated with favorable prognosis in metastatic nasopharyngeal carcinoma. Med Oncol. 2014;31(8):80. doi:10.1007/s12032-014-0080-y25023050
   PubMed Web of Science ®Google Scholar
• WuJ, ZhangC, ZhangG, et al. Association between pretreatment serum apolipoprotein A1 and prognosis of solid tumors in Chinese population: a systematic review and meta-Analysis. Cell Physiol Biochem. 2018;51(2):575–588. doi:10.1159/00049527730466099
   PubMedGoogle Scholar
• WangXP, LiXH, ZhangL, et al. High level of serum apolipoprotein A-I is a favorable prognostic factor for overall survival in esophageal squamous cell carcinoma. BMC Cancer. 2016;16(1):516. doi:10.1186/s12885-016-2502-z27444612
   PubMed Web of Science ®Google Scholar
• ZhangY, YangX. Prognostic significance of pretreatment apolipoprotein A-I as a noninvasive biomarker in cancer survivors: a meta-analysis. Dis Markers. 2018;2018:1034037. doi:10.1155/2018/103403730510601
   PubMed Web of Science ®Google Scholar
• YangYS, ShangQX, YuanY, et al. Comparison of long-term quality of life in patients with esophageal cancer after Ivor-Lewis, Mckeown, or Sweet esophagectomy. J Gastrointest Surg. 2019;23(2):225–231. doi:10.1007/s11605-018-3999-z30298418
   PubMed Web of Science ®Google Scholar
• HelminenO, MrenaJ, SihvoE. Can we increase the resection rate by minimally invasive approach? Experience from 100 minimally invasive esophagectomies. J Oncol. 2019;2019:3809383. doi:10.1155/2019/380938330915119
   PubMed Web of Science ®Google Scholar
• RiceTW, IshwaranH, HofstetterWL, et al. Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus. 2016;29(8):897–905. doi:10.1111/dote.1253327905172
   PubMed Web of Science ®Google Scholar
• IasonosA, SchragD, RajGV, et al. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:10.1200/JCO.2007.12.979118323559
   PubMed Web of Science ®Google Scholar
• SalamiA, AbbasAE, PetrovR, et al. Comparative analysis of clinical, treatment, and survival characteristics of basaloid and squamous cell carcinoma of the esophagus. J Am Coll Surg. 2018;226(6):1086–1092. doi:10.1016/j.jamcollsurg.2017.10.01929133264
   PubMed Web of Science ®Google Scholar
• ChoKJ, JangJJ, LeeSS, et al. Basaloid squamous carcinoma of the oesophagus: a distinct neoplasm with multipotential differentiation. Histopathology. 2000;36(4):331–340. doi:10.1046/j.1365-2559.2000.00851.x10759947
   PubMed Web of Science ®Google Scholar
• KlaaseJM, HulscherJB, OfferhausGJ, et al. Surgery for unusual histopathologic variants of esophageal neoplasms: a report of 23 cases with emphasis on histopathologic characteristics. Ann Surg Oncol. 2003;10(3):261–267. doi:10.1245/ASO.2003.05.02912679311
   PubMed Web of Science ®Google Scholar
• ChenSB, WengHR, WangG, et al. Basaloid squamous cell carcinoma of the esophagus. J Cancer Res Clin Oncol. 2012;138(7):1165–1171. doi:10.1007/s00432-012-1180-822419439
   PubMed Web of Science ®Google Scholar
• ImamhasanA, MitomiH, SaitoT, et al. Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas. Hum Pathol. 2012;43(11):2012–2023. doi:10.1016/j.humpath.2012.02.01022607702
   PubMed Web of Science ®Google Scholar
• GeorgilaK, VyrlaD, DrakosE. Apolipoprotein A-I (ApoA-I), immunity, inflammation and cancer. Cancers (Basel). 2019;11(8):1097. doi:10.3390/cancers11081097
   PubMed Web of Science ®Google Scholar
• WeltiJ, LogesS, DimmelerS, et al. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Invest. 2013;123(8):3190–3200. doi:10.1172/JCI7021223908119
   PubMed Web of Science ®Google Scholar
• GaoF, VasquezSX, SuF, et al. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways. Integr Biol (Camb). 2011;3(4):479–489. doi:10.1039/c0ib00147c21283904
   PubMed Web of Science ®Google Scholar
• SuF, KozakKR, ImaizumiS, et al. Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer. Proc Natl Acad Sci USA. 2010;107(46):19997–20002. doi:10.1073/pnas.100901010721041624
   PubMed Web of Science ®Google Scholar
• KobayashiY, KashimaH, WuRC, et al. Mevalonate pathway antagonist suppresses formation of serous tubal intraepithelial carcinoma and ovarian carcinoma in mouse models. Clin Cancer Res. 2015;21(20):4652–4662. doi:10.1158/1078-0432.CCR-14-336826109099
   PubMed Web of Science ®Google Scholar
• TietgeUJ, MaugeaisC, CainW, et al. Overexpression of secretory phospholipase A(2) causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I. J Biol Chem. 2000;275(14):10077–10084. doi:10.1074/jbc.275.14.1007710744687
   PubMed Web of Science ®Google Scholar
• FrondeliusK, BorgM, EricsonU, et al. Lifestyle and dietary determinants of serum apolipoprotein A1 and apolipoprotein B concentrations: cross-sectional analyses within a Swedish cohort of 24,984 individuals. Nutrients. 2017;9(3):211. doi:10.3390/nu9030211
   PubMed Web of Science ®Google Scholar
• YeJ, LuoQY, WangXP, et al. Serum apolipoprotein A-I combined with C-reactive protein serves as a novel prognostic stratification system for colorectal cancer. Cancer Manag Res. 2019;11:9265–9276. doi:10.2147/CMAR.S21559931802946
   PubMed Web of Science ®Google Scholar
• VälimäkiM, LaitinenK, YlikahriR, et al. The effect of moderate alcohol intake on serum apolipoprotein A-I-containing lipoproteins and lipoprotein (a). Metabolism. 1991;40(11):1168–1172. doi:10.1016/0026-0495(91)90211-E1834916
   PubMed Web of Science ®Google Scholar
• BradburyKE, CroweFL, ApplebyPN, et al. Serum concentrations of cholesterol, apolipoprotein A-I and apolipoprotein B in a total of 1694 meat-eaters, fish-eaters, vegetarians and vegans. Eur J Clin Nutr. 2014;68(2):178–183. doi:10.1038/ejcn.2013.24824346473
   PubMed Web of Science ®Google Scholar
• van WorkumF, BerkelmansGH, KlarenbeekBR, et al. McKeown or Ivor Lewis totally minimally invasive esophagectomy for cancer of the esophagus and gastroesophageal junction: systematic review and meta-analysis. J Thorac Dis. 2017;9(S8):S826–S833. doi:10.21037/jtd.2017.03.17328815080
   PubMed Web of Science ®Google Scholar
• DengJ, SuQ, RenZ, et al. Comparison of short-term outcomes between minimally invasive McKeown and Ivor Lewis esophagectomy for esophageal or junctional cancer: a systematic review and meta-analysis. Onco Targets Ther. 2018;11:6057–6069. doi:10.2147/OTT.S16948830275710
   PubMed Web of Science ®Google Scholar